Back to search

National and Kapodistrian University of Athens

Μελέτη της φαρμακοκινητικής της κολιμυκίνης και μελέτη της φαρμακοκινητικής μετά από χορήγηση δόσης φόρτισης στους ασθενείς της μονάδας εντατικής θεραπείας (Μ.Ε.Θ)

Abstract

dc:description

The increase in the incidence of antimicrobial resistance among Gram – negative bacteria in combination with the dry antimicrobial drug development pipeline poses a serious threat in the management of infections and has led to the revival of colistin. Colistin is systemically administered in the form of colistin methanesulfonate (CMS), an inactive pro-drug which is hydrolyzed to colistin that exhibits bactericidal activity. The optimal dose of colistin is unclear due to the lack of accurate pharmacokinetic information, since most available data are based on microbiological assays that are considered erroneous. In the present study we analyzed the pharmacokinetics of colistin in 18 critically ill patients with infections caused by Gram negative bacteria after a dose of 3 million IU every 8 hours. Venous blood samples were collected immediately before and at multiple occasions after the first and the fourth infusions. Plasma CMS and colistin were determined by a liquid chromatography-tandem mass spectrometry method and population pharmacokinetic analysis was performed with the NONMEM program. The estimated half-life was 14.4 hours, whereas the maximum concentrations of the drug in plasma were 0.60 mg/L and 2.3 mg/L after the first dose and at steady state respectively. The implications of these findings are very important since the obtained plasma colistin concentrations were insufficient for the 48 hours after initiation of treatment and the administration of a loading dose would be beneficial. Subsequently, a pharmacokinetic study of CMS and colistin following a loading dose of 6 million IU and a maintenance dose of 3 million IU every 8 hours was conducted in 10 critically ill patients and the colistin concentrations were found 1.34mg/L after the first dose. The present study was completed by evaluating the pharmacokinetics of CMS and colistin in a population of 19 critically ill patients with the application of a loading dose of 9 million IU and a maintenance dose of 4.5 million IU every 12 hours. The maximum colistin concentrations in plasma were 2.50 mg/L after the loading dose, values above the MIC breakpoints for the Enterobacteriaceae and A.baumannii (2mg/L).In conclusion, a reevaluation of the CMS dosage appears warranted. We recommend the application of a loading dose of 6 – 9 million IU and a maintenance dose of 4.5 million IU with a longer interval to be given every 12 hours.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karaiskos, Ilias
  • Καραΐσκος, Ηλίας

Subjects

dc:subject × 16

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41925

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karaiskos, Ilias; Καραΐσκος, Ηλίας. Μελέτη της φαρμακοκινητικής της κολιμυκίνης και μελέτη της φαρμακοκινητικής μετά από χορήγηση δόσης φόρτισης στους ασθενείς της μονάδας εντατικής θεραπείας (Μ.Ε.Θ). National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/41925